Hecheng Pharmaceutical Releases Interim Performance, Shareholders to Receive Dividend of 498 Million CNY, Up 24.6% Year-on-Year
Hecheng Pharmaceutical (01681) released its interim performance as of June 30, 2025. During this period, the company achieved revenue of CNY15.69 billion, up 23.7% year-on-year; shareholders are expec